GOEDDEL DAVID V Insider Profile

88 Followers
GOEDDEL DAVID V

GOEDDEL DAVID V
NGM Biopharmaceuticals (NGM)
Director, Ten Percent Owner

Ranked #939 out of 102,052 Corporate Insiders

Profitable Transactions

70%
37 out of 53 Profitable Transactions

Average Return

+25.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$359M
51.81%
31.45%
16.74%
A breakdown of GOEDDEL DAVID V's holdings

Insider Roles

RAPT Therapeutics
(RAPT)
Director, Ten Percent Owner
NGM Biopharmaceuticals
(NGM)
Director, Ten Percent Owner
Tenaya Therapeutics
(TNYA)
Director, Ten Percent Owner
Roles that GOEDDEL DAVID V holds in companies

Most Profitable Insider Trade

Stock:
RAPT Therapeutics
(RAPT)
Rating:Informative Buy
Date:Nov 04, 2019 - Nov 04, 2020
Return:+155.60%
The most profitable trade made by GOEDDEL DAVID V

GOEDDEL DAVID V's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
NGM Biopharmaceuticals
Jan 25, 2023
Director, Ten Percent Owner
Informative Buy
$49.40K
$112.91M
RAPT Therapeutics
Nov 04, 2019
Director, Ten Percent Owner
Uninformative Buy
$186.03M
Tenaya Therapeutics
Jan 23, 2023
Director, Ten Percent Owner
Informative Buy
$173.65K
$60.12M
List of latest transactions for each holding click on a transaction to see GOEDDEL DAVID V's performance on stock

GOEDDEL DAVID V insider profile FAQ

What is the percentage of profitable transactions made by GOEDDEL DAVID V?
The percentage of profitable transactions made by GOEDDEL DAVID V is 70%.
    What is the average return per transaction made by GOEDDEL DAVID V?
    The average return per transaction made by GOEDDEL DAVID V is 25.70%.
      What stocks does GOEDDEL DAVID V hold?
      GOEDDEL DAVID V holds: NGM, RAPT, TNYA stocks.
        What was GOEDDEL DAVID V’s latest transaction?
        GOEDDEL DAVID V latest transaction was an Informative Buy of $49.40K.
          What was GOEDDEL DAVID V's most profitable transaction?
          GOEDDEL DAVID V’s most profitable transaction was an Informative Buy of RAPT stock on November 4, 2019. The return on the trade was 155.60%.
            What is GOEDDEL DAVID V's role in NGM Biopharmaceuticals?
            GOEDDEL DAVID V's role in NGM Biopharmaceuticals is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.